Crossmark

A Prospective Study to Evaluate the Effect of Therapeutic Drug Monitoring-Based Posaconazole Prophylaxis on Invasive Fungal Infection Rate During Acute Myeloid Leukemia Induction Therapy

Crossref DOI link: https://doi.org/10.1007/s12288-023-01709-3

Published Online: 2023-10-29

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boppana, Mounika

Sengar, Manju https://orcid.org/0000-0002-3509-5682
Jain, Hasmukh https://orcid.org/0000-0002-9947-7065
Gurjar, Murari

Ambotkar, Madhavi

Gota, Vikram https://orcid.org/0000-0001-6348-6667
Bonda, Avinash

Bagal, Bhausaheb https://orcid.org/0000-0001-9754-0182
Thorat, Jayashree

Gokarn, Anant

Nayak, Lingaraj https://orcid.org/0000-0001-9520-795X
Shetty, Nitin

Baheti, Akshay

Mokal, Smruti

Kannan, Sadhana

Shetty, Alok

Eipe, Thomas https://orcid.org/0000-0001-9004-1233
Funding

Funding for this research was provided by:

Tata Memorial Centre Research Administrative Council
License Information

Text and Data Mining valid from 2023-10-29

Version of Record valid from 2023-10-29
More Information

Article History

Received: 13 May 2023

Accepted: 4 October 2023

First Online: 29 October 2023

Declarations

:

: The authors have declared no conflicts of interest.

: All authors declare that they approve the final version of the manuscript. In addition, the authors have declared no conflicts of interest. The study was approved by the institutional ethics committee and was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The study was registered in the Clinical Trials Registry – India (CTRI) (CTRI/2017/06/008810).

: Patients were enrolled after obtaining a written informed consent. For patients aged 14–17 years assent and guardian consent were taken.

Document is current

Any future updates will be listed below